Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Capital Medical University
ClinicalTrials.gov Identifier:
NCT00815594
First received: December 29, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2009
  Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)